FRMD4B

FRMD4B (GRSP1/KIAA1013) is a FERM domain-containing scaffolding protein that couples ARF guanine nucleotide exchange factor signaling to PI3K/insulin inputs and cell junction remodeling (PMID:11445584, PMID:29947801). It binds GRP1-family ARF-GEFs (GRP1, ARNO, Cytohesin-1) through antiparallel heptad-repeat coiled-coil interactions, re-equilibrating these GEFs from homodimers into Grsp1-containing heterodimers without altering GRP1 phosphoinositide headgroup binding (PMID:11445584, PMID:20527794). Endogenous GRSP1 exists essentially entirely in complex with GRP1, and the pair co-translocates from cytoplasm to plasma membrane ruffles upon insulin stimulation (PMID:11445584). Through this membrane recruitment, FRMD4B regulates AKT phosphorylation and the membrane levels of junction proteins beta-catenin and ZO-1, and is required for maintenance of retinal external limiting membrane integrity, where a recruitment-deficient S938P variant suppresses photoreceptor dysplasia (PMID:29947801). In neurons, FRMD4B supports process elongation in a manner linked to sustained MAPK/ERK phosphorylation, and loss of frmd4b in zebrafish impairs cranial motor neuron development, implicating it as a candidate gene for ocular congenital cranial dysinnervation disorders (PMID:40162949, PMID:41155374).

1. 2001 High

   Established FRMD4B/GRSP1 as a dedicated binding partner of the ARF-GEF GRP1 that links GRP1 to insulin signaling, answering whether GRSP1 has a defined molecular partner and where it acts.

   Evidence cDNA expression library screen with radiolabeled GRP1 probe, domain-mapping co-IP, insulin-stimulated co-translocation imaging in CHO cells, and immunodepletion from lung lysates

   PMID:11445584

   Open questions at the time

   • Functional consequence of the GRSP1-GRP1 complex on downstream ARF activation not resolved
   • Whether membrane recruitment requires GRP1 binding or FRMD4B's own determinants not dissected
2. 2010 High

   Defined the biophysical basis and selectivity of FRMD4B-GEF complex formation, answering how Grsp1 assembles with GRP1-family proteins and whether it alters their lipid binding.

   Evidence In vitro reconstitution with analytical ultracentrifugation, FRET orientation analysis, and liposome co-sedimentation

   PMID:20527794

   Open questions at the time

   • Functional output of heterodimerization on GEF catalytic activity not measured
   • Cellular consequence of antiparallel orientation untested in vivo
3. 2018 Medium

   Connected FRMD4B membrane recruitment to AKT signaling and junction protein turnover, answering whether the insulin-driven translocation has a tissue-level functional role.

   Evidence Chemical mutagenesis screen identifying the S938P (Tvrm222) suppressor allele, in vitro cell-surface recruitment assay, Western blot for pAKT and junction proteins, and retinal histology in mouse models

   PMID:29947801

   Open questions at the time

   • Direct mechanism linking FRMD4B to AKT phosphorylation not established
   • Whether junction protein changes are cause or consequence of altered AKT signaling unresolved
   • Role of GRP1/ARF activity in the retinal phenotype not tested
4. 2025 Medium

   Demonstrated an in vivo developmental requirement for FRMD4B in cranial motor neuron formation, answering whether the gene contributes to neuronal patterning relevant to human disease.

   Evidence G0 and F2 germline CRISPR/Cas9 frmd4b knockout in zebrafish with phenotypic analysis of cranial motor development

   PMID:40162949

   Open questions at the time

   • No molecular mechanism for the cranial motor phenotype resolved
   • Causal human variant in oCCDD patients not demonstrated
5. 2025 Low

   Implicated FRMD4B in neuronal process elongation via a MAPK/ERK-linked pathway, addressing a cell-autonomous neuronal function.

   Evidence CRISPR/Cas13 knockdown in primary cortical neurons and N1E-115 cells with morphometric analysis, MAPK/ERK Western blot, and hesperetin pharmacological rescue

   PMID:41155374

   Open questions at the time

   • MAPK/ERK linkage is indirect with no direct epistasis experiment
   • Whether the GRP1/ARF or AKT pathways mediate this effect not tested
   • Pharmacological rescue does not establish FRMD4B acts directly upstream of ERK

• How the FRMD4B-ARF-GEF complex mechanistically couples membrane recruitment to AKT, MAPK/ERK, and junction remodeling across retinal and neuronal contexts remains unresolved.
• No structural model of the FERM domain in function
• No demonstrated effect of FRMD4B on ARF GTPase loading in cells
• Unifying mechanism across retina and neurons not established